(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

COMPOSTO DE UREIA, SEUS USOS NA ANTAGONIZAÇÃO DE RECEPTOR DE LPA1, MEDICAMENTO, ANTAGONISTA DE RECEPTOR DE LPA1 E FÁRMACO

Em ExigênciaInvention PatentPCT · JP2020029003

Application data

Number

112022000598

Type

Invention Patent

Filing

07/29/2020

Publication

03/03/2022

PCT

JP2020029003

Progress at the INPI

Technical opinion to answer
  1. Filing07/29/20
  2. Publication03/03/22
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The INPI issued a technical opinion on patentability. The applicant must respond for examination to continue.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 05/07/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

TAISHO PHARMACEUTICAL CO., LTD.

JP

See this company's full portfolio

Inventors

F. U. (pessoa física)

JP

K. H. (pessoa física)

JP

S. K. (pessoa física)

JP

Y. I. (pessoa física)

JP

Y. K. (pessoa física)

JP

Y. U. (pessoa física)

JP

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Parecer de pré-exame

#6.23

05/07/2024

RPI 2783

Notificação de entrada na fase nacional - PCT

#1.3

03/03/2022

RPI 2669

Alteração de dados cadastrais

#1.1

01/25/2022

RPI 2664

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.